ENDRA Life Sciences Inc. (NDRA )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol NDRA
- Company ENDRA Life Sciences Inc.
- Price $3.49
- Changes Percentage -7.69
- Change -0.2908
- Day Low $3.45
- Day High $3.63
- Year High $665
- Year Low $2.97
- Market Cap $1,927,500
- Price Avg 50 EMA (D) $4.08
- Price Avg 200 EMA (D) $25.52
- Exchange NASDAQ
- Volume 24,810
- Average Volume 112,144
- Open $3.49
- Previous Close $3.78
- EPS -69.58
- PE -0.05
- Earnings Announcement 2025-05-12 10:59:00
- Shares Outstanding $536,908
Company brief: ENDRA LIFE SCIENCES INC. (NDRA )
- Healthcare
- Medical - Diagnostics & Research
- Mr. Francois Michelon
- https://www.endrainc.com
- US
- N/A
- 06-30-2017
- US29273B3024
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.